AzTrials
AzTrials

Polycystic Ovarian Syndrome (PCOS)SSAETNCT07157371

Effects of Aerobic Exercise Training Program in Females With Insulin Resistant Polycystic Ovarian Syndrome

A study testing Supervised structured aerobic exercise training and Walk in people with Polycystic Ovarian Syndrome (PCOS) and Aerobic Exercise, run by Riphah International University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Design: RCT Randomized Clinical Trial Non Probability Convenient Sampling Technique Duration of treatment: 25 weeks 2 groups; (group A=30) SSAET +Normal routine medication+ Normal Dietary Plan , Other group (Group B=30) with normal routine medication + Normal Dietary Plan. Read more about this study

Who is it for?
Ages 18 to 35 years, women only
What is being tested?
Supervised structured aerobic exercise training and Walk
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
1 Apr 2025to 1 Oct 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18 To 35 years Females.
  • Insulin resistant PCOS type.
  • Already Diagnosed patients form gynecological department according to the Rotterdam criteria.
  • Both Married and unmarried females.
  • Nulliparous females.

Who cannot join

  • Post pill PCOS, Inflammatory PCOS \& Adrenal PCOS
  • Any psychological disease or disorder
  • Any systemic disease other than PCOS (cushing syndrome, thyroid dysfunction, etc)
  • Orthopedic conditions (including fracture, dislocation, etc)
  • Any surgery in past 6 months.
  • Involved in any other exercise regimen at the same time.
  • Having any specialized diet plan.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Sculpture Gym

    Lahore, 53710

Other trials in Pakistan

About this study

Official title: Effects of Supervised Structured Aerobic Exercise Training Program on Serum BDNF, Androgens Level, Menstrual Irregularity and Quality of Life in Females With Insulin Resistant Polycystic Ovarian Syndrome

Design: RCT Randomized Clinical Trial Non Probability Convenient Sampling Technique Duration of treatment: 25 weeks 2 groups; (group A=30) SSAET +Normal routine medication+ Normal Dietary Plan , Other group (Group B=30) with normal routine medication + Normal Dietary Plan.

Patients will be enrolled in experimental group according to speeds test.

Read more

HYPOTHESIS:

Alternate hypothesis:

There is difference on the effects of Supervised Structured Aerobic Exercise Training Program on serum BDNF, androgens level, menstrual irregularity and quality of life in females with insulin resistant polycystic ovarian syndrome.

Null Hypothesis:

There is no difference on the effects of Supervised Structured Aerobic Exercise Training Program on serum BDNF, androgens level, menstrual irregularity and quality of life in females with insulin resistant polycystic ovarian syndrome.

OBJECTIVES:

To determine the effects of Supervised Structured Aerobic Exercise Training Program on quality of life in women with PCOS.

  1. To determine the effect of Supervised Structured Aerobic Exercise Training Program on BDNF levels in women with PCOS.
  2. To determine the effect of Supervised Structured Aerobic Exercise Training Program on mental health (stress, depression, anxiety) in women with PCOS.
  3. To determine the effect of Supervised Structured Aerobic Exercise Training Program on BMI in women with PCOS.
  4. To determine the effect of Supervised Structured Aerobic Exercise Training Program on menstrual irregularity in women with PCOS.
  5. To determine the effect of Supervised Structured Aerobic Exercise Training Program on Aerobic fitness in women with PCOS.
  6. To determine the effect of Supervised Structured Aerobic Exercise Training Program on androgens level in PCOS.
  7. To determine the effect of Supervised Structured Aerobic Exercise Training Program on Lipid accumulation product in PCOS.
  8. To determine the effect of Supervised Structured Aerobic Exercise Training Program on Glycemic control in PCOS.
Read the detailed description

Polycystic ovarian syndrome is a very common systemic disease consisting of hormone problem for women of childbearing age. Women with PCOS may not ovulate, have high levels of androgens, and have many small cysts on the ovaries. PCOS can cause missed or irregular menstrual periods, excess hair growth, acne, infertility, and weight gain. BDNF is linked with exercise and its receptors are also in ovaries. Hence, if the levels of BDNF falls below average then it plays an important role in hyperandrogenism and this often accompanied with lack of physical activity. Another factor, lipid accumulation product is closely related to glucose intolerance and wight gain which eventually gives rise to hyperandrogenism and it eventually affects the quality of life of females with polycystic ovarian syndrome.

It will be a randomized controlled trial. Convenient sampling technique would be used.

Inclusion criteria would be females of age 18-35 years, insulin resistant polycystic ovarian syndrome, pre-diagnosed, married and un married both, diabetic \& nulliparous females.

Exclusion criteria would be post pill, Inflammatory \& Adrenal PCOS, any psychological disease or disorder, any systemic disease other than PCOS (cushing syndrome, thyroid dysfunction, renal tumor, etc), Orthopedic conditions (including fracture, dislocation, etc), any surgery in past 6 months, involved in any other exercise regimen at the same time, having any specialized diet plan \& Pregnant females.

Patients enrolled in the study will be divided randomly by even odd method. (Group A=30) will be given the Supervised Structured Aerobic Exercise Treatment Program for 12 weeks along with their normal routine medications given to them by their gynecologist.

(Group B=30) will have the conventional treatment of only the routine medications given by their gynecologist and brisk walk plan. Assessment of variables would be taken from both groups at baseline, 12 weeks and 25 weeks of intervention. 2 ml of blood would be taken through syringe and plasma would be tested for BDNF levels through ELISA, Androgens level through Free Androgen Index and quality of Life through Polycystic Ovarian Syndrome Quality of Life Questionnaire (PCOSQ). Aerobic fitness through Canadian fitness test and VO2max. Glycated hemoglobin would be tested for glucose intolerance through HbA1c test.

Keywords: Polycystic ovary syndrome, Poly cystic ovarian syndrome, sclerocystic ovaries, aerobic fitness, aerobic exercise, supervised, hyperandrogenism, PCOS, SHBG, testosterone, Quality of life.

HYPOTHESIS:

Alternate hypothesis:

There is difference on the effects of Supervised Structured Aerobic Exercise Training Program on serum BDNF, androgens level, menstrual irregularity and quality of life in females with insulin resistant polycystic ovarian syndrome.

Null Hypothesis:

There is no difference on the effects of Supervised Structured Aerobic Exercise Training Program on serum BDNF, androgens level, menstrual irregularity and quality of life in females with insulin resistant polycystic ovarian syndrome.

STUDY GROUPS:

Group 1: (Experimental Group n=30) Conventional Drugs treatment of PCOS advised by the medical specialist along with the Supervised Structured Aerobic Exercise Training program (SSAET) for 25 weeks.(29) Speed of the treadmill will be calculated and maintained at 60 to 70% of MHR in each session with progression of duration and inclination only. The intervention in experimental group would be divided into 5 phases of 5 weeks duration each.

DURATION OF EXERCISE SESSION

The patients in experimental group would be treated for a single session per day, at 3 days per week for 25 weeks. The details of each phase are given below:

Phase-1: In first phase the duration of each session would be 10 minutes and the total duration of exercise will be 30 minutes per week.

Phase-2: In the second phase the duration of a single session would be 20 minutes and duration21 of exercise per week will be 60 minutes.

Phase-3: In the third phase the duration of a single session would be 30 minutes and the total duration of exercise per week will be 90 minutes.

Phase-4: In the fourth phase the duration of each phase would be 40 minutes and the total duration of exercise per week will be 120 minutes.

Phase-5: In the last phase and final phase the duration of a single session would be 50 minutes and the total duration of exercise will be 150 minutes per week, as recommended by the American heart Association (AHA).

INCLINATION OF TREADMILL WALKING RAMP WITH GROUND (30) Phase-1: Normal Phase-2: 3 degrees Phase-3: 6 degrees Phase-4: 9 degrees Phase-5: 12 degrees Intensity of progression would be measured by the subject's Borgs rate of perceived exertion (RPE) according to the 15-point Borg Scale as per individual load.

Warm up and cool down protocol:

  1. Without treadmill: warm up protocol involves breathing exercises, Stretching exercises (pectoralis major, triceps, biceps, hamstrings \& calf stretch) and cool down exercises as ankle-toe movements of 5-10 min duration.
  2. On tread mill: the warming-up phase, which consisted in walking on the treadmill for 5 minutes at low intensity (30% of MHR), at a 0% slope before the actual phase, and the cooling phase, which consist of in walking on the treadmill for 5 minutes at low intensity (30% of MHR) at 0% slope in each session. The MHR would be calculated according to the equation (HR= 220-age).

Group 2: (Control Group n=30) Conventional Drugs treatment of PCOS advised by the medical specialist along with the simple sustained brisk walk advised at a self-selected brisk pace described as "faster than normal walking but a pace that could be sustained for at least 20 min." Subjects would be instructed to complete at least three walks per week, each walk of 20 to 60 min duration.

TOOLS:

  1. Modified polycystic ovarian syndrome Quality of Life Questionnaire (MPCOSQ)- Quality of life
  2. MIQ (Menstrual Irregularity Questionnaire)- Menstrual irregularity
  3. Women's weight in kilograms divided by the square of height in meters- BMI
  4. Aerobic fitness- I. Canadian home fitness test, bench test from 8cm for 3 min II. Indirect estimation of VO2 max by formula VO2 max (walking) = (0.2 x speed of treadmill) + (0.9 x speed x treadmill grade) + 3.5
  5. BDNF levels- ELISA
  6. Androgens level- Serum SHBG will be measured by coated-tube immunoradiometric assay using commercial kits. Testosterone will be measured by RIA using commercial enzymatic kits. Free androgen index (FAI) will be calculated as testosterone/SHBG × 100. Clinical hyperandrogenism (a score of 6 or higher on the modified Ferriman-Gallwey scale)
  7. Mental health- (Stress, depression \& Anxiety) by DASS
  8. Lipid Accumulation Product -Triglycerides test and waist circumference The LAP would be calculated as [waist circumference (centimeters) - 58] × [triglycerides (millimoles per liter)]
  9. Glycemic control-HbA1c levels (Pre-diabetic condition as HbA1c 5.7-6.4% according to American Diabetic Association)
Being tested
Supervised structured aerobic exercise training, Walk
Keywords
Insulin resistant, Supervised, aerobic exercise, SSAET, PCOS, metabolic syndrome
Medical subject headings
Polycystic Ovary Syndrome, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Supervised structured aerobic exercise trainingOther

    Also called Aerobic exercises

    Supervised structured aerobic exercise plan will be conducted in gym by the physiotherapist

  • WalkOther

    Females with PCOS will be instructed to do a walk at home with medications

Study groups in NCT07157371
Study groupRoleWhat they receive
Interventional group- PCOSExperimental25 weeks of supervised structured aerobic exercise treatment program will be applied on the females with PCOS in the gym setting.
Receives: Other: Supervised structured aerobic exercise training
Second group- PCOSActive comparatorwalk will be asked for these patients and their feedback will be taken through cell phone
Receives: Other: Walk

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression Anxiety Stress Scale (DASS)

    Mental Health (Stress, depression \& Anxiety) by DASS 21

    Scoring Process:

    1. Sum the scores for each subscale: Add the scores for the 7 items within each subscale (Depression, Anxiety, and Stress).
    2. Multiply by 2: Multiply the sum of each subscale by 2 to get the final score for each area (Depression, Anxiety, and Stress).
    3. Interpret the scores:

    The resulting scores are then interpreted using the provided severity levels for each subscale.

    Severity Levels:

    The DASS-21 provides severity levels for each subscale:

    Depression:

    Normal (0-9), Mild (10-13), Moderate (14-20), Severe (21-27), Extremely Severe (28+).

    Anxiety:

    Normal (0-7), Mild (8-9), Moderate (10-14), Severe (15-19), Extremely Severe (20+).

    Stress:

    Normal (0-14), Mild (15-18), Moderate (19-25), Severe (26-33), Extremely Severe (34+).

    > Higher the scores means more severity and less healthy.

    Measured: 12 weeks and 25 weeks

  2. Polycystic ovarian syndrome Quality of Life Questionnaire (PCOSQOL)

    This is a tool to measure quality of life in females with Polycystic Ovarian syndrome.

    There are total 35 Questions in it. Scoring: Summate each item to give a total score. A low score represents that a lower quality of life, a higher score represents a lesser to no impact on quality of life.

    Measured: 12 weeks and 25 weeks

  3. MIQ (Menstrual Irregularity Questionnaire)

    Measures menstrual irregularity The MIQ is a 6-point questionnaire, and the total score reflects the overall impact of heavy menstrual bleeding on the woman's life. Higher scores indicate a greater negative impact of heavy menstrual bleeding on the woman's quality of life. The MIQ helps healthcare professionals understand the severity of the problem and tailor treatment accordingly.

    Measured: 12 weeks and 25 weeks

  4. 3 min bench step test II. Indirect estimation of VO2 max by formula VO2 max (walking) = (0.2 x speed of treadmill) + (0.9 x speed x treadmill grade) + 3.5

    To measure Aerobic fitness.

    YMCA 3-minute Bench Step Test:

    You step up and down on a 30 cm (12-inch) step for three minutes at a consistent pace, and your heart rate is measured afterward to estimate fitness for 1 minute through carotid artery. The more fit you are, the lower your recovery heart rate will be, meaning a lower number is a better score.

    Compare to Charts:

    Use your age and gender to find the appropriate fitness rating chart, such as the YMCA charts.

    Determine Your Level:

    The chart will show whether your 1-minute heart rate falls into categories like excellent, good, above average, average, or below average fitness.

    YMCA FEMALES Scoring:

    Excellent <109 Above Average 110 - 117 Average 118 - 134 Below Average 135-137 Poor >137

    Measured: 12 weeks and 25 weeks

  5. ELISA

    BDNF levels

    Measured: 12 and 25 weeks

  6. Androgens level

    Serum SHBG will be measured by coated-tube immunoradiometric assay using commercial kits. Testosterone will be measured by RIA using commercial enzymatic kits. Free androgen index (FAI) will be calculated as testosterone/SHBG × 100.

    Clinical hyperandrogenism (a score of 6 or higher on the modified Ferriman-Gallwey scale)

    Measured: 12 weeks and 25 weeks

Secondary outcomes (3)
  1. HOMA-IR for Glycemic control

    The HOMA-IR score is calculated using your fasting glucose and fasting insulin levels:

    HOMA-IR = (Fasting Glucose x Fasting Insulin) / 22.5

    Measured: 12 weeks and 25 weeks

  2. Lipid Accumulation Product

    Triglycerides test and waist circumference The LAP would be calculated as [waist circumference (centimeters) - 58] × [triglycerides (millimoles per liter)]

    Measured: 12 weeks and 25 weeks

  3. BMI

    Women's weight in kilograms divided by the square of height in meters

    Measured: 12 weeks and 25 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2025
  2. Study start1 Apr 2025
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion1 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07157371
Sponsor's protocol ID
REC/RCR/ & AHS/23/1103
Acronym
SSAET
Status last verified
Aug 2025
First submitted
3 Aug 2025
Last updated
5 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Shakil-Ur-Rehman S, Karimi H, Gillani SA. Effects of supervised structured aerobic exercise training program on fasting blood glucose level, plasma insulin level, glycemic control, and insulin resistance in type 2 diabetes mellitus. Pak J Med Sci. 2017 May-Jun;33(3):576-580. doi: 10.12669/pjms.333.12023.

    PubMed 28811774

Questions about this trial

What is this clinical trial studying?

A study testing Supervised structured aerobic exercise training and Walk in people with Polycystic Ovarian Syndrome (PCOS) and Aerobic Exercise, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression Anxiety Stress Scale (DASS) (time frame: 12 weeks and 25 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07157371, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in